PRICE T ROWE ASSOCIATES INC /MD/ - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$25,094,000
-15.8%
911,191
-49.6%
0.00%
-33.3%
Q1 2021$29,788,000
-17.9%
1,806,445
-8.3%
0.00%
-25.0%
Q4 2020$36,287,000
+45.7%
1,968,931
+7.6%
0.00%
+33.3%
Q3 2020$24,897,000
-28.5%
1,829,295
-5.8%
0.00%
-25.0%
Q2 2020$34,807,000
+2122.7%
1,942,373
+1136.7%
0.00%
Q1 2020$1,566,000
+13.0%
157,064
-7.7%
0.00%
Q4 2019$1,386,000170,2090.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,833,120$52,169,0008.78%
Copernicus Capital Management, LLC 227,719$3,099,0002.95%
FRAZIER MANAGEMENT LLC 2,182,789$29,708,0002.67%
Baupost Group 18,044,239$242,393,0002.62%
Prosight Management, LP 282,100$3,839,0001.83%
RTW INVESTMENTS, LP 3,745,286$50,973,0001.23%
GREAT POINT PARTNERS LLC 943,339$12,839,0001.16%
DAFNA Capital Management LLC 190,930$2,599,0000.84%
Endurant Capital Management LP 176,710$2,405,0000.71%
Artal Group S.A. 1,400,000$19,054,0000.46%
View complete list of TRANSLATE BIO INC shareholders